1. Home
  2. MEC vs DSGN Comparison

MEC vs DSGN Comparison

Compare MEC & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mayville Engineering Company Inc.

MEC

Mayville Engineering Company Inc.

HOLD

Current Price

$35.78

Market Cap

885.7M

Sector

Industrials

ML Signal

HOLD

Logo Design Therapeutics Inc.

DSGN

Design Therapeutics Inc.

HOLD

Current Price

$10.96

Market Cap

819.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEC
DSGN
Founded
1945
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
885.7M
819.6M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
MEC
DSGN
Price
$35.78
$10.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$24.33
$15.25
AVG Volume (30 Days)
666.6K
1.2M
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.65
N/A
Revenue Next Year
$8.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.10
$3.33
52 Week High
$36.24
$17.25

Technical Indicators

Market Signals
Indicator
MEC
DSGN
Relative Strength Index (RSI) 78.15 45.02
Support Level $17.20 $9.78
Resistance Level N/A $11.18
Average True Range (ATR) 2.09 0.62
MACD 0.49 0.04
Stochastic Oscillator 93.12 52.99

Price Performance

Historical Comparison
MEC
DSGN

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, powersports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly, and logistic services.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion.

Share on Social Networks: